Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis/Experiment 2/Signature 1
From BugSigDB
Source: Figure 4; Table 8
Description: Significant differences in relative abundance identified by LEfSe analysis between the three groups (Control, G1G2 and G3G4). At the species level, the untreated group(control) is shown in blue, the intensive treatment group(G1G2) in red and the consolidation treatment group(G3G4) in green. The length of the column represents the influence of significantly different species in relative abundance (LDA scores > 2)
Abundance in Group 1: increased abundance in continuation phase 12–14-month of the treatment (G3G4 group)
| NCBI | Quality Control | Links |
|---|---|---|
| Bifidobacterium adolescentis | ||
| Butyricicoccus pullicaecorum | ||
| Megamonas hypermegale | ||
| Kluyvera georgianaKluyvera georgiana |
Revision editor(s): Nuerteye
